Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Boc-Abu-OH

    • Product Name Boc-Abu-OH
    • Alias Boc-2-Aminobutyric acid
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    584820

    Productname Boc-Abu-OH
    Iupacname tert-butyl (S)-2-aminobutanoate
    Chemicalformula C9H19NO4
    Casnumber 73860-38-9
    Appearance White to off-white solid
    Purity Typically ≥98%
    Solubility Soluble in organic solvents (e.g., DCM, DMF)
    Meltingpoint 81-85 °C
    Storagetemperature 2-8 °C
    Protectinggroup Boc (tert-butoxycarbonyl)
    Chirality L-isomer
    Function Amino acid derivative for peptide synthesis
    Synonyms tert-Butoxycarbonylaminobutyric acid

    As an accredited Boc-Abu-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Boc-Abu-OH is supplied in a sealed amber glass vial containing 5 grams, labeled with product details and safety information.
    Shipping Boc-Abu-OH is shipped in a sealed, labeled container, protected from moisture and light. Standard chemical shipping procedures are followed, including appropriate hazard labeling and documentation. The package complies with regulations for non-hazardous laboratory chemicals and is delivered via certified carriers to ensure product stability and traceability during transit.
    Storage **Boc-Abu-OH** should be stored in a tightly sealed container at 2–8°C, protected from moisture and light. Store in a dry, well-ventilated area, away from incompatible substances like strong oxidizing agents. Properly label the container and avoid prolonged exposure to air to maintain stability and prevent degradation. Handle under appropriate laboratory safety protocols.
    Application of Boc-Abu-OH

    Applications of Boc-Abu-OH in Industrial Manufacturing

    Boc-Abu-OH (tert-Butyloxycarbonylaminobutyric acid) is a protected alpha-amino acid intermediate with established use in high-purity peptide synthesis and pharmaceutical manufacturing. As an experienced manufacturer, we deliver Boc-Abu-OH specifically engineered for demanding downstream processes requiring strict quality and regulatory adherence. Below, we outline authentic, differentiated application scenarios within core segments that value this material's unique properties.

    1. Synthetic Peptide API Manufacturing

    Peptide-based active pharmaceutical ingredients (APIs) represent the largest industrial sector for N-protected amino acid derivatives, with Boc-Abu-OH serving as a protected intermediate for introducing Homoalanine residues during solid-phase peptide synthesis (SPPS). Pharmaceutical manufacturers rely on our material to achieve precise sequence control and high purity, minimizing side reactions during chain elongation. We supply production-scale volumes tailored to large-molecule contract manufacturing organizations (CMOs) and innovator companies working under validated GMP conditions.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP, EP, JP Pharmacopoeial Monograph Compliance where applicable
    • 21 CFR Part 210/211 (US FDA Drug GMP Regulations)
    • EU GMP, Annex 13 requirements for APIs

    Typical usage ratio

    • 1.0–1.5 molar equivalents per targeted residue when coupled onto peptide resin
    • Adjusted according to HPLC monitoring for chain assembly yield and purity

    Downstream process integration

    • Direct feeding into automated or manual SPPS reactors during core resin loading or fragment coupling stages
    • N-terminal protecting group removal downstream using acidolysis after chain assembly completion

    Final product types

    • Pharmaceutical-grade synthetic peptides (e.g., peptide hormones, therapeutic peptides)
    • Peptide drug substance intermediates

    2. Custom Peptide Research Reagents Production

    Contract research organizations (CROs) and specialized laboratories routinely utilize Boc-protected amino acids for small-scale custom peptide synthesis. Boc-Abu-OH's side-chain protection and high purity facilitate reliable assembly of research-grade peptides, including screening libraries and analytical standards. We manufacture under controlled environments to meet stringent lot traceability and reproducibility expectations that accompany advanced peptide design projects for biotech and academic sectors.

    Industry compliance standards

    • ISO 9001:2015 Quality Management System
    • ISO/IEC 17025 for chemical testing and calibration labs
    • Internal analytical validation protocols for peptide research materials

    Typical usage ratio

    • 1.0–1.2 molar equivalents per coupling step depending on peptide length
    • Titrated based on scale (typically 0.05–0.2 mmol for manual syntheses)

    Downstream process integration

    • Manual or automated solid-phase peptide synthesis incorporating Boc-Abu-OH during elongation phase
    • Final removal of Boc group prior to peptide resin cleavage and HPLC purification

    Final product types

    • High-purity, non-GMP-grade research peptides
    • Biochemical assay standards
    • Peptide analog libraries for medicinal chemistry and structural biology applications

    3. Diagnostic Peptide Kit Manufacturing

    In vitro diagnostic (IVD) companies formulate peptide substrates and controls for assay development, disease marker quantification, or immunodiagnostic test kits. Boc-Abu-OH is employed at defined stages in sequence-specific peptide substrate synthesis required for quantitative and qualitative diagnostic formulations, where batch consistency and impurity control are essential for regulatory clearance. Our materials support downstream applications that demand stringent validation and minimal cross-contamination risks.

    Industry compliance standards

    • ISO 13485 Medical Devices—Quality Management Systems for IVDs
    • FDA 21 CFR Part 820 (Quality System Regulation)
    • CE-IVD and IVDR (EU regulation for diagnostic products)

    Typical usage ratio

    • 0.9–1.1 molar equivalents per synthesis cycle; verified by LC/MS for sequence integrity
    • Modified based on peptide substrate length and required batch size (typically 100–1000 mg scale)

    Downstream process integration

    • Used in semi-automated or manual solid-phase synthesis robots for labeled and unlabeled peptide substrate manufacturing
    • Final deprotection and purification (RP-HPLC) before inclusion in IVD assay kits

    Final product types

    • Peptide substrates for ELISA and immunoassay kits
    • Synthetic peptide calibrators and controls for clinical chemistry analyzers
    • Diagnostic reference standards

    4. GMP-Grade Peptide Injectable Formulation Intermediate

    Specialty pharma manufacturers producing injectable biologics or peptide therapeutics require Boc-Abu-OH as an intermediate to introduce noncoded amino acids improving peptide stability, solubility, or pharmacokinetic profile. These applications necessitate tightly controlled synthesis and release testing meeting injectable drug regulations, with full traceability and documentation from raw material qualification through batch release to market.

    Industry compliance standards

    • ICH Q11 Development and Manufacture of Drug Substances
    • USP <1046> Biotechnology-Derived Articles
    • EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use
    • FDA CMC Guidance for Sterile Drug Products

    Typical usage ratio

    • 1.05–1.2 molar equivalents, as determined by process development analytical protocols
    • Ratio adjusted based on required final peptide sequence characteristics and GMP batch validation results

    Downstream process integration

    • Incorporation during protected amino acid coupling stages in multipurpose GMP peptide synthesis suites
    • Followed by strict in-process controls (IPC), impurity profiling, and robust deprotection protocols

    Final product types

    • Sterile injectable peptide APIs and intermediates for regulatory submission
    • Peptide bulk drugs for hospital and specialty pharmacy use
    Free Quote

    Competitive Boc-Abu-OH prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Boc-Abu-OH: Inside the Manufacturer's Experience

    Understanding Boc-Abu-OH from the Factory Floor

    As a chemical manufacturer, seeing the journey of Boc-Abu-OH from raw feedstock to finished product offers a unique perspective on its role in pharmaceutical and peptide synthesis. Boc-Abu-OH, or N-tert-Butyloxycarbonyl-L-2-aminobutyric acid, starts as a batch process involving precise temperature control, select solvents, and a careful addition of reactants. Our process prioritizes purity and consistency. Every batch passes through rigorous lot-to-lot analysis, using HPLC and chiral purity checkpoints, before reaching the hands of our buyers.

    The finished acid appears as a white solid. Each lot of Boc-Abu-OH meets a strict purity threshold, typically above 98%. Technical staff pay close attention to moisture content, since residual water can impact coupling efficiency downstream. This product offers a Boc-protected amino group and a free C-terminus, making it an attractive building block in solid phase peptide synthesis workflows. Our team has refined the process to control impurity levels, especially for base-sensitive clients who notice byproducts that can slow down their synthesis or even compromise the final yield.

    Practical Performance in Peptide Synthesis

    Boc-Abu-OH’s core value comes out during peptide chain extension. Chemists reach for this molecule to insert an Abu residue with a sterically protected N-terminal. We've worked with customers scaling research peptides, as well as those in kilo-scale custom manufacturing, so it's clear how reliability matters. An improperly protected amino acid or erratic lot purity can cause expensive delays.

    Boc-Abu-OH’s tert-butoxycarbonyl group protects the amine from side reactions during coupling. This ensure clean peptide bonds form without N-terminal scrambling or unwanted branching. After synthesis, the Boc group can be selectively removed by acids like TFA, freeing up the primary amine for further chemical manipulation. As peptide chemistries move beyond standard proteinogenic amino acids, manufacturers like us see increased demand for non-standard building blocks like Boc-Abu-OH. Even though alanine and leucine derivatives still top global sales, the diversity in drug discovery workflows feeds steady orders for Abu analogues.

    Specifications, Storage, and Shelf Stability Insights

    Manufacturing quality Boc-Abu-OH means maintaining more than just formal purity. Our teams focus on critical chemical properties: non-racemic composition (L-form), control of metallic traces, and management of residual solvents. Typical specs demand a melting point between 82-86°C, with less than 0.2% moisture by Karl Fischer titration. The robust Boc group helps stability. Batches stored in sealed packaging at room temperature show negligible decomposition after one year, with laboratory data supporting their integrity over two years if kept away from humidity.

    Clients often ask about storage practices. Based on our experience and customer feedback, storing Boc-Abu-OH in screw-capped HDPE bottles, or in aluminum foil pouches for larger quantities, assigns an extra layer of protection against atmospheric moisture. Ambient temperature suffices. Refrigeration or freezing, sometimes preferred for Fmoc- or unprotected amino acids, is unnecessary here due to the Boc group’s resilience toward hydrolysis or light.

    Comparing Boc-Abu-OH to Other Protected Amino Acids

    Seeing the differences between Boc-Abu-OH and other amino acids in the warehouse comes down to two main questions: How does it streamline chemistry, and what unique challenges might arise? For most peptide chemists, the alternatives are Fmoc-Abu-OH or even unprotected Abu-OH. Compared to Fmoc analogues, Boc-Abu-OH tolerates acidic workup without premature deprotection. Fmoc groups lift in base, so they can unravel during basic cleavage or saponification steps. In facilities that use both Boc and Fmoc protection strategies, the workflow chosen shapes waste streams, choice of solvents, and even the sequence of steps in synthesis.

    Getting pure, odor-free product from a manufacturer means controlling not just the base chemistry, but also the work-up and drying. Our drying process for Boc-Abu-OH involves multiple stages: vacuum sweep to remove traces of solvents, low-heat oven drying for moisture, and closed transfer to oxygen-free storage. By comparison, unprotected Abu-OH often holds water or even traces of solvent, especially if these aren’t removed during a final recrystallization. Boc protection allows the product to ship securely and sit on laboratory shelves for months with little degradation.

    Why Purity Consistency Matters to End Users

    As manufacturers, we see first-hand where small changes in material consistency show up in research or pilot-scale manufacturing. A medicinal chemist working on a twelve-residue peptide cannot risk unpredictable side chain reactions, especially if the starting amino acids change from batch to batch. Delivering reproducibility means investing in NMR and LC-MS as batch-release tools, not just spot checks. Constant calibration of balances, tracking environmental controls, and investing in upgraded purification columns are part of the daily routine.

    Customer complaints almost always tie back to trace impurities — either residual acids or unidentified side-products from incomplete Boc installation. Doubts over raw material quality delay entire projects. Peptide yield drops, and reverse-phase HPLC reveals splitting or tailing peaks. End-users in discovery projects tolerate little deviation, as regulatory compliance for APIs and clinical peptide candidates tightens. We’ve fielded requests for custom sub-lots, extra COAs, and even video walk-throughs of our purification suite for these reasons. In the end, delivering on these expectations keeps trust and builds long-term collaborations.

    Boc-Abu-OH and Scale-Up Knowledge from Real Orders

    Orders for Boc-Abu-OH range from ten-gram vials in academic labs to drum-scale lots for contract production. Working with kilogram volumes demands fresh approaches to solvent recovery, impurity isolation, and waste reduction. For scale-up, our technical specialists optimize reaction stoichiometries to reduce overuse of expensive protecting agents. For peptide makers, scale isn’t just a bigger bottle, but a production line calibrated to microgram sensitivity. We update SOPs after every 100-batch milestone, learning from previous runs where minor errors amplify at larger volumes. No two large-scale synthesis jobs look alike.

    Some process improvements come from straightforward fixes. Purge lines on crystallization tanks minimize cross-contamination. Dedicated low-iron glassware avoids metallic contamination. In rare cases, solving recurring problems takes multidisciplinary team meetings or even visits to customers’ sites to observe in-process product use. For orders above 100 kilograms, shipping logistics also demand certified packaging compatible with maritime or air cargo rules. The paperwork and quality-control chain can take longer than the actual chemical synthesis in these scenarios.

    Supporting the Drug Discovery Pipeline

    The drive to deliver Boc-Abu-OH stems from the drug pipeline’s demand for precision. Non-standard amino acids like Abu appear in sequences modifying biostability, folding, or introducing therapeutic functionality into new peptides. We see requests not just for L-Boc-Abu-OH but also for D-form, isotopically labeled versions, and derivatives catering to protease-resistance or backbone-modified scaffolds.

    A decade ago, only a handful of firms pursued non-natural amino acids for research. Now, nearly every biotech company factors in sequence optimization, and that means diversified demand for building blocks like Boc-Abu-OH. Our role is to guarantee predictable performance, batch documentation, and technical data to keep their work on track. Regulatory documentation such as elemental analysis and trace metal content reports helps customers cross hurdles in IND submissions and patent filings.

    Evaluating Environmental and Safety Considerations

    Manufacturing Boc-Abu-OH isn’t just an exercise in yield optimization or purity chasing. Environmental and safety considerations remain front and center. Managing solvent streams, eliminating chlorinated residues, and efficiently capturing all mother liquors from crystallization waste prevent discharge issues and regulatory headaches. Our operators use closed-handling stations for Boc-anhydride, eliminating airborne particulate hazards and reducing accidental exposure.

    Byproducts, including t-butyl alcohol and traces of isobutylene, require safe venting or on-site neutralization. Internal audits track storage of all flammable and reactive agents used in Abu-OH protection, and regular retraining keeps all shop-floor workers updated on the safest practices for handling potentially allergenic residues. In larger batch manufacturing, supporting systems include vapor scrubbing, temperature alarms, and careful use of non-reactive fittings to prevent catastrophic leaks.

    Collaborating directly with downstream users, we sometimes recommend process adaptations or alternate workups to lower the risk profile. Understanding that small testing labs lack dedicated extraction hoods or storage rooms, we offer technical notes about appropriate protective gloves, eye protection, and post-operation cleaning to minimize risk.

    Trends Shaping Boc-Abu-OH Markets

    Several trends sharpen the market for Boc-Abu-OH. As global production capacity grows, customers gain access to a wider range of suppliers and must navigate differences in product quality, regulatory status, and after-sales technical support. Some research clients select Boc-Abu-OH on documented consistency, others look for price, but many now ask about trace-level documentation on elemental impurities and residual solvents to support regulatory filings. Our teams invest in method validation and GLP documentation to keep pace.

    Growing numbers of clinical peptides entering the market mean more frequent audits and more frequent requests for ICH-compliant documentation on each lot of amino acid. Reliable traceability allows us to track any reported anomaly back to a specific shift, reactor, or purification lot, then fine-tune processes rapidly. Investing in digital batch tracking and cloud-based certificate handling streamlines communication and boosts confidence for both sides.

    Future-Proofing Boc-Abu-OH Manufacturing

    Staying a trusted source for Boc-Abu-OH depends on understanding customer needs before pain points arise. We focus on workforce training, automating hazardous operations, and continually updating analytical methods to handle increasingly stringent customer and regulatory requirements. Equipment lifespan, vendor qualification, and in-line monitoring factor into every decision. On-boarding new team members takes them through the full process chain, from raw material vetting to final COA sign-off, to create accountability at every stage.

    Automatic moisture and volatile organic analysis platforms now speed up batch release. We’ve engineered QC processes so that even new team members can catch a deviation and quarantine a batch within minutes. Surveying professional peptide chemists, we adapt packaging and labeling to fit their bench flow — clear codes for lot tracking, tamper-evident seals, and hazard pictograms sized for lab bench use. Continuous investment in safety and customer communication keeps the focus on reliability, not just yield.

    Conclusion: The Manufacturer’s Lens on Boc-Abu-OH

    Every container of Boc-Abu-OH traces back through a long chain of chemical, operational, and practical experience. As manufacturers, we hear directly from users with challenging peptide syntheses, unusual process setups, and tight regulatory deadlines. Responding with rapid feedback, open technical support, and ongoing process improvements turns feedback into better workflows and stronger chemistry. The way Boc-Abu-OH makes its mark in research and industry traces back to a philosophy grounded in hands-on learning, collaboration, and detail-oriented production methods honed batch by batch on the factory floor.